1. Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 8(10):918-28
2. Alter, J., Sennoga, C.A., Lopes, D., Eckserley, R.J., Wells, D.J. (2009) Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer. Ultrasound in Medicine and Biology 35(6):976-84.
3. Muntoni F and D.J. Wells (2007) Genetic treatments in muscular dystrophy. Current Opinions in Neurology 20:590–594.
4. Wells, D.J. (2006) Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy. Journal of Muscle Research and Cell Motility 27:387-398.
5. Wells, D.J. and K.E. Wells (2005). What do animal models have to tell us regarding Duchenne Muscular Dystrophy? Acta Myologica. 24: 172-180.
6. Wells K.E., Fletcher, S., Mann, C.J., Wilton, S.D. and Wells, D.J. (2003) Enhanced in vivo delivery of antisense oligonucleotide to restore dystrophin expression in adult mdx mouse muscle. FEBS Lett. 552:145-149.
Links
Contact details:
Professor Dominic J Wells, MA VetMB PhD MRCVS
Neuromuscular Disease Group.
Department of Veterinary Basic Sciences
Royal Veterinary College, Camden campus
Royal College Street
London NW1 0TU, U.K.
Tel: +44 (0)20 3214 8024
E-mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it